Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing

Normal-karyotype acute myeloid leukemia (NK-AML) is a highly malignant and cytogenetically heterogeneous hematologic cancer. We searched for somatic mutations from 10 pairs of tumor and normal cells by using a highly efficient and reliable analysis workflow for whole-exome sequencing data and perfor...

Full description

Saved in:
Bibliographic Details
Main Authors: Seong Gu Heo, Eun Pyo Hong, Ji Wan Park
Format: Article
Language:English
Published: BioMed Central 2013-03-01
Series:Genomics & Informatics
Subjects:
Online Access:http://genominfo.org/upload/pdf/gni-11-46.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568840306819072
author Seong Gu Heo
Eun Pyo Hong
Ji Wan Park
author_facet Seong Gu Heo
Eun Pyo Hong
Ji Wan Park
author_sort Seong Gu Heo
collection DOAJ
description Normal-karyotype acute myeloid leukemia (NK-AML) is a highly malignant and cytogenetically heterogeneous hematologic cancer. We searched for somatic mutations from 10 pairs of tumor and normal cells by using a highly efficient and reliable analysis workflow for whole-exome sequencing data and performed association tests between the NK-AML and somatic mutations. We identified 21 nonsynonymous single nucleotide variants (SNVs) located in a coding region of 18 genes. Among them, the SNVs of three leukemia-related genes (MUC4, CNTNAP2, and GNAS) reported in previous studies were replicated in this study. We conducted stepwise genetic risk score (GRS) models composed of the NK-AML susceptible variants and evaluated the prediction accuracy of each GRS model by computing the area under the receiver operating characteristic curve (AUC). The GRS model that was composed of five SNVs (rs75156964, rs56213454, rs6604516, rs10888338, and rs2443878) showed 100% prediction accuracy, and the combined effect of the three reported genes was validated in the current study (AUC, 0.98; 95% confidence interval, 0.92 to 1.00). Further study with large sample sizes is warranted to validate the combined effect of these somatic point mutations, and the discovery of novel markers may provide an opportunity to develop novel diagnostic and therapeutic targets for NK-AML.
format Article
id doaj-art-58d15c0e349b470c831a566db0d6fc8a
institution Kabale University
issn 1598-866X
2234-0742
language English
publishDate 2013-03-01
publisher BioMed Central
record_format Article
series Genomics & Informatics
spelling doaj-art-58d15c0e349b470c831a566db0d6fc8a2025-02-03T00:00:52ZengBioMed CentralGenomics & Informatics1598-866X2234-07422013-03-01111465110.5808/GI.2013.11.1.4677Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome SequencingSeong Gu Heo0Eun Pyo Hong1Ji Wan Park2Department of Medical Genetics, Hallym University College of Medicine, Chuncheon 200-702, Korea.Department of Medical Genetics, Hallym University College of Medicine, Chuncheon 200-702, Korea.Department of Medical Genetics, Hallym University College of Medicine, Chuncheon 200-702, Korea.Normal-karyotype acute myeloid leukemia (NK-AML) is a highly malignant and cytogenetically heterogeneous hematologic cancer. We searched for somatic mutations from 10 pairs of tumor and normal cells by using a highly efficient and reliable analysis workflow for whole-exome sequencing data and performed association tests between the NK-AML and somatic mutations. We identified 21 nonsynonymous single nucleotide variants (SNVs) located in a coding region of 18 genes. Among them, the SNVs of three leukemia-related genes (MUC4, CNTNAP2, and GNAS) reported in previous studies were replicated in this study. We conducted stepwise genetic risk score (GRS) models composed of the NK-AML susceptible variants and evaluated the prediction accuracy of each GRS model by computing the area under the receiver operating characteristic curve (AUC). The GRS model that was composed of five SNVs (rs75156964, rs56213454, rs6604516, rs10888338, and rs2443878) showed 100% prediction accuracy, and the combined effect of the three reported genes was validated in the current study (AUC, 0.98; 95% confidence interval, 0.92 to 1.00). Further study with large sample sizes is warranted to validate the combined effect of these somatic point mutations, and the discovery of novel markers may provide an opportunity to develop novel diagnostic and therapeutic targets for NK-AML.http://genominfo.org/upload/pdf/gni-11-46.pdfacute myeloid leukemiaDNA sequence analysisgenetic variationrisk assessment
spellingShingle Seong Gu Heo
Eun Pyo Hong
Ji Wan Park
Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
Genomics & Informatics
acute myeloid leukemia
DNA sequence analysis
genetic variation
risk assessment
title Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
title_full Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
title_fullStr Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
title_full_unstemmed Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
title_short Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
title_sort genetic risk prediction for normal karyotype acute myeloid leukemia using whole exome sequencing
topic acute myeloid leukemia
DNA sequence analysis
genetic variation
risk assessment
url http://genominfo.org/upload/pdf/gni-11-46.pdf
work_keys_str_mv AT seongguheo geneticriskpredictionfornormalkaryotypeacutemyeloidleukemiausingwholeexomesequencing
AT eunpyohong geneticriskpredictionfornormalkaryotypeacutemyeloidleukemiausingwholeexomesequencing
AT jiwanpark geneticriskpredictionfornormalkaryotypeacutemyeloidleukemiausingwholeexomesequencing